A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
10/2002
10/24/2002	CA2443897A1 Transporters and ion channels
10/24/2002	CA2443777A1 Therapeutic and diagnostic uses of antibody specificity profiles
10/24/2002	CA2443699A1 Phenyl heterocyclyl ether
10/24/2002	CA2443697A1 1,4-disubstituted benzo-fused compounds
10/24/2002	CA2443568A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	CA2443487A1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
10/24/2002	CA2443408A1 Kinases and phosphatases
10/24/2002	CA2443244A1 Enzymes
10/24/2002	CA2443234A1 Isoxaxole derivatives as inhibitors of src and other protein kinases
10/24/2002	CA2443229A1 Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv
10/24/2002	CA2442943A1 Anti-inflammatory fatty alcohols and fatty acid esters useful as antigen carriers
10/24/2002	CA2442729A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/24/2002	CA2442118A1 Improved edible compositions for lowering cholesterol
10/24/2002	CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/24/2002	CA2431553A1 Cxcr3 antagonists
10/24/2002	CA2407349A1 Novel stable crystal of thiazolidinedione derivative and process for producing the same
10/23/2002	WO2001080854A1 Activators for peroxisome proliferator-activated receptor
10/23/2002	EP1251137A2 Use of insulin-like growth factor agonist peptides
10/23/2002	EP1251130A1 Fused purine derivatives
10/23/2002	EP1251128A1 Cyclohexylamine derivatives as subtype selective N-methyl-D-aspartate antagonists
10/23/2002	EP1250930A2 Mixture of herbs as ATP synthesis activator
10/23/2002	EP1250849A1 Morinda citrifolia (Noni) enhanced animal food product
10/23/2002	EP1250455A1 Antisense inhibition of ptp1b expression
10/23/2002	EP1250432A2 Nuclear hormone receptors
10/23/2002	EP1250358A1 Therapeutic peptides
10/23/2002	EP1250347A1 Antisense modulation of akt-3 expression
10/23/2002	EP1250338A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors
10/23/2002	EP1250328A1 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses
10/23/2002	EP1250323A2 Compounds having hypolipidemic and hypocholesterolemic activities, process for their preparation and pharmaceutical compositions containing them
10/23/2002	EP1250321A1 Glyburide composition
10/23/2002	EP1250157A1 Antisense modulation of inducible nitric oxide synthase expression
10/23/2002	EP1250156A1 Method for nucleic acid transfection of cells
10/23/2002	EP1250146A2 Use of neurotoxins for treating diabetes
10/23/2002	EP1250131A2 Modulation of the blood-brain barrier transporter for leptin
10/23/2002	EP1250127A1 A method of administering a medicinal aerosol formulation
10/23/2002	EP1250126A2 Transepithelial delivery of glp-1 derivatives
10/23/2002	EP1250124A2 Slimming cosmetic composition comprising as active agent a plant extract containing a plant natriuretic peptide (pnp)
10/23/2002	EP1250116A1 Pharmaceutical and cosmetic carrier or composition for topical application
10/23/2002	EP1250055A1 Immune modulation with death receptor-induced apoptosis
10/23/2002	EP1140191B1 Combinations of ileal bile acid transport inhibitors and nicotinic acid derivatives for cardiovascular indications
10/23/2002	EP0914118B1 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators
10/23/2002	EP0894089B1 Novel heterocyclic compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
10/23/2002	CN1376166A Peptide that lower blood glucose levels
10/23/2002	CN1376156A Benzodiazepin derivatives, the production and use thereof
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1376069A Methods and compositions for reducing sympathomimetic-induced side effects
10/23/2002	CN1376062A Use of amino acids for making medicine for treating to insulin-resistance
10/23/2002	CN1375494A Iso-indolo-indolone compound, their preparation methods and drug compositions comprising the same
10/23/2002	CN1375490A Novel indeno indolone compound, its preparation method and drug composition comprising the same
10/23/2002	CN1375318A Hypoglycemic granule of ten ingredients and its prepn
10/23/2002	CN1375317A hypoglycemic Yikang capsule
10/23/2002	CN1375302A Ketangwan pills as diabetes treating medicine capable of inducing insulin synthesis and its prepn.
10/23/2002	CN1375287A Veterinary mixed suspension injection containing chlorocyaniosaliamine or its sodium salt
10/23/2002	CN1375285A Zinc glycinate capsule
10/23/2002	CN1093130C Substituted pyrido 6,6-bicyclic derivatives
10/23/2002	CN1093124C Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma
10/23/2002	CN1092986C CoA oral preparation for reducing blood fat and its preparation method and application
10/23/2002	CN1092961C Pharmaceutical with anti-high-blood-sugar
10/23/2002	CN1092938C Diabetic supplement bar
10/22/2002	US6469174 Substituted pyrrolobenzimidazoles for treating inflammatory diseases
10/22/2002	US6469162 Compounds with chelation affinity and selectivity for first transition series elements: use in medical therapy and diagnosis
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469045 Thalidomide and various related compounds such as thalidomide precursors, analogs, metabolites and hydrolysis products; oral administration
10/22/2002	US6469037 Prophylactic or therapeutic drug for renal diseases
10/22/2002	US6469032 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease
10/22/2002	US6469025 For the prophylaxis or treatment of a disease or disorder in a mammal in which the extravasation of leukocytes plays a role; inhibiting the binding of alpha 4 integrins to their ligands
10/22/2002	US6469024 Tetrahydroisoquinoline analogs useful as growth hormone secretagogues
10/22/2002	US6469018 Compounds
10/22/2002	US6469013 Therapeutic compounds
10/22/2002	US6469004 Benzoheterocycles and their uses as MEK inhibitors
10/22/2002	US6468999 Treating anxiety, depression and other central nervous system disorders in humans and animals
10/22/2002	US6468992 Phosphonic acid diester derivatives
10/22/2002	US6468989 Gel compositions containing metronidazole
10/22/2002	US6468986 Composition comprising polynucleotide and polycationic agent which exhibits net positive electrical charge at physiological ph, and is capable of mediating entry of polynucleotides into cell
10/22/2002	US6468975 Glucocorticoid receptor antagonists that are preferably liver selective and are useful in treatment of diabetes
10/22/2002	US6468974 Oligopeptides that provide desirable in vitro and in vivo growth hormone releasing activity and have at least one other desirable biological activity such as increased retention time
10/22/2002	US6468962 Nutritional intervention composition for enhancing and extending satiety
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468556 Administering conjugated linoleic acid, cla
10/22/2002	US6468542 Germination activated Ganoderma lucidum spores and method for producing the same
10/22/2002	US6468536 Proteins extracted with perchloric acid from animal organs for preparation of medicaments active against autoimmune diseases, such as atherosclerosis, arthritis, multiple sclerosis, and diabetes; proteins uk 101 and uk 114; sequence
10/22/2002	US6468533 Polyclonal or monoclonal antibody that inhibits high mobility group 1 protein mediated activation of inflammatory cytokine cascade; sepsis
10/22/2002	US6468507 Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer
10/22/2002	CA2118670C Pharmaceutical compositions in semisolid form and a device for administration thereof
10/22/2002	CA2106954C Dry starch-iodine pharmaceutical formulations
10/17/2002	WO2002081686A2 Nucleic acids binding a neuropeptide
10/17/2002	WO2002081668A2 Desaturase genes and uses thereof
10/17/2002	WO2002081528A1 Polymer specifically recognizing bile acid, process for producing the same, bile acid-absorbing polymer and cholesterol-lowering agents
10/17/2002	WO2002081521A2 Osteoprotegerin in milk
10/17/2002	WO2002081499A2 Somatostatin agonists
10/17/2002	WO2002081475A1 Jun kinase inhibitors
10/17/2002	WO2002081467A1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
10/17/2002	WO2002081463A1 Antagonists of mcp-1 function and methods of use thereof
10/17/2002	WO2002081460A1 Lipid lowering biphenylcarboxamides
10/17/2002	WO2002081454A1 Derivatives of aryl acids, their use in medicine, process for their preparation and pharmaceutical compositions containing them
10/17/2002	WO2002081453A1 Thiohydantoins and use thereof for treating diabetes
10/17/2002	WO2002081449A1 Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
10/17/2002	WO2002081443A1 Novel guanidino compounds
10/17/2002	WO2002081430A2 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
10/17/2002	WO2002081428A1 Benzene compound and salt thereof

1 ... 958 959 960 961 962 963 964 965 966 967 968 969 970 971 972 973 974 975 976 977 978 ... 1298